In this comparison, syndecan-1 and heparan sulfate plasma concentrations are significantly higher and ADAMTS13 significantly lower in patients progressing from pneumonia to severe pulmonary failure (ARDS) (Figure 2). Here, SDC1 is linked to acute respiratory distress syndrome.